Page last updated: 2024-11-04

carbamylhydrazine and Diseases, Metabolic

carbamylhydrazine has been researched along with Diseases, Metabolic in 1 studies

carbamylhydrazine: RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"Owing to the parallelism between the in vitro insulin mimicry and the in vivo improvement of glucose handling elicited by benzylamine in rodents, the SSAO/VAP-1 substrates, with stronger effects on human adipocytes than benzylamine, show promising applications for the treatment of insulin resistance."3.76SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders. ( Attané, C; Balogh, B; Brenachot, X; Carpéné, C; Dunkel, P; Földi, A; Iffiú-Soltesz, Z; Mátyus, P; Mercader, J; Valet, P, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mercader, J1
Iffiú-Soltesz, Z1
Brenachot, X1
Földi, A1
Dunkel, P1
Balogh, B1
Attané, C1
Valet, P1
Mátyus, P1
Carpéné, C1

Other Studies

1 other study available for carbamylhydrazine and Diseases, Metabolic

ArticleYear
SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.
    Future medicinal chemistry, 2010, Volume: 2, Issue:12

    Topics: 3T3 Cells; Adipocytes; Adipokines; Amine Oxidase (Copper-Containing); Animals; Apelin; Benzylamines;

2010